Research Article
Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary Intervention
Table 4
Changes in CK-MB, cTnI, h-FABP, NO, and vWF levels before and after PCI in the control and trimetazidine groups, expressed as x̅ ± s.
| ||||||||||||||||||||||||||||||||||||||||||
ΔCK-MB: change in creatine kinase-muscle/brain, ΔcTnI: change in cardiac troponin I, Δh-FABP: change in heart-type fatty acid-binding protein, ΔNO: change in nitric oxide, and ΔvWF: change in von Willebrand factor. . |